Dr. Fisher is a RHS Patient and Professor Emerita, University of North Carolina at Chapel Hill. Early in her career as a scientist, Dr. Fisher was initially mis-diagnosed and has lived with facial paralysis for over 35 years. She is passionate about helping other RHS patients navigate the care they need in this rare but devastating condition. Trained as a scientist, Dr. Fisher appreciates the importance of science-based therapies.

Dr. Miller is the Director of UNC Facial Nerve Center. Dr. Miller experienced facial paralysis as a college student and has dedicated his professional career to the care of patients with facial nerve disorders. He directs one of the busiest facial nerve centers in the world.

​

Dr. Sellek is a Board Member

Assistant Professor in the Department of Otolaryngology, Head and Neck Surgery, Co-Director UNC Neurotology/Otology and Skull Base Surgery Fellowship, Medical Co-Director of Children’s Cochlear Implant Center.

Dr. Selleck is a neurotologist who regularly sees patients with facial, hearing and vestibular nerve disorders.​

Heather is a Speech Language Pathologist at UNC Facial Nerve Center. Heather Davis Cuevas is a specialist in facial nerve disorders. She works closely with Drs. Miller and Selleck to treat RHS patients.

Brandon is a Physical Therapist at UNC Center for Rehabilitation Care. Brandon Peer has specific training in vestibular nerve disorders. He works with ENT physicians to help evaluate and provide treatment to patients with vertigo and balance disorders.

Michael is a Mental Health and Inclusion Educator. For nearly twenty years, Michael S. Miller was a managing director of The Vanguard Group of Valley Forge, Pennsylvania, where he retired in 2015. Before joining Vanguard, he was president of an independent broker-dealer. Earlier, Mr. Miller practiced law in Washington, D.C., becoming a partner in his firm in 1985. Mr. Miller is currently a member of numerous boards with publicly-traded companies and civic and academic nonprofit organizations. Mr.Miller is passionate about using his skills to help organizations serving trauma victims, including facial paralysis patients.

Kristen Huehbner is a seasoned Advocacy leader with over 15 years of experience driving meaningful change for people living with cancer, genetic, autoimmune, and rare diseases. She currently serves as Director of Patient Advocacy & Engagement, Vaccines at GSK, where she leads strategic partnerships with patient advocacy groups, coalitions, and public health organizations to strengthen vaccine confidence, expand equitable access, and elevate community voices in public health decision‑making. 

Craig Stock is a retired writer and editor whose career focused on financial journalism, communications, and investor education. He spent 20 years at The Vanguard Group and previously worked as a financial writer, editor, and columnist for The Philadelphia Inquirer. Craig is passionate about public service and continues to serve on several nonprofit boards.